Arcutis Biotherapeutics, Inc.
ARQT· Nasdaq
ARQTArcutis Biotherapeutics, Inc.
Filed Nov 4, 2021 · 10-Q · 35 days after period end · 0001787306-21-000030
| Metric | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|
| Revenue | $0.00 | — | — |
| Net Income | -$56.98M | -$38.20M | -$14.48M |
| EPS Diluted | -$1.14 | -$1.01 | -$7.56 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Arcutis Biotherapeutics, Inc. · CIK 1787306 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 4, 2021 · 35 d after period end
